Extended siponimod release via low-porosity PLGA fibres: a comprehensive three-month in vitro evaluation for neovascular ocular diseases

The sustained release of siponimod from low-porosity electrospun PLGA fibers offers an alternative treatment for ocular neovascular diseases, potentially reducing intravitreal injection frequency to fewer than four injections per year.